Bothwell, K. D., Folaron, M., & Seshadri, M. (2016). Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer. Cancers (Basel).
Citação norma ChicagoBothwell, Katelyn D., Margaret Folaron, and Mukund Seshadri. "Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer." Cancers (Basel) 2016.
MLA CitationBothwell, Katelyn D., Margaret Folaron, and Mukund Seshadri. "Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer." Cancers (Basel) 2016.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.